Flonase and Gangrene - a phase IV clinical study of FDA data

Summary:

Gangrene is reported as a side effect among people who take Flonase (fluticasone propionate), especially for people who are female, 60+ old, also take Lipitor, and have Crohn's disease.

The phase IV clinical study analyzes which people have Gangrene when taking Flonase. It is created by eHealthMe based on reports of 73,331 people who have side effects when taking Flonase from the FDA, and is updated regularly.

What is Flonase?

Flonase has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 75,441 Flonase users. Check the latest studies of Flonase.

What is Gangrene?

Gangrene (body tissue dies) is found to be associated with 652 drugs and 721 conditions by eHealthMe. Check the latest studies of Gangrene.

On Jul, 12, 2026

73,331 people reported to have side effects when taking Flonase.
Among them, 21 people (0.03%) have Gangrene.

Among these 21 people:

What is the gender of people who have Gangrene when taking Flonase? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Gangrene when taking Flonase? *

What are other drugs people take besides Flonase? *

What are other side effects people have besides Gangrene? *

Anaemia (lack of blood): 7 people, 33.33%
Hypoaesthesia (reduced sense of touch or sensation): 6 people, 28.57%
Weakness: 5 people, 23.81%
Pain: 5 people, 23.81%
Unresponsive To Stimuli: 5 people, 23.81%
Cellulitis (infection under the skin): 5 people, 23.81%
Diarrhea: 4 people, 19.05%
Skin Ulcer: 4 people, 19.05%
Fatigue (feeling of tiredness): 4 people, 19.05%
Exostosis (formation of new bone on the surface of a bone): 4 people, 19.05%

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 19.05%
Asthma: 4 people, 19.05%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 19.05%
Type 2 Diabetes: 2 people, 9.52%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 9.52%
Immunodeficiency Common Variable: 2 people, 9.52%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 9.52%
Cough: 1 person, 4.76%
Drowsiness: 1 person, 4.76%
Diarrhea: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Flonase and have Gangrene?

- Check whether Gangrene is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Flonase:

Flonase (75,441 reports)

Gangrene treatments and more:

Gangrene (7,194 reports)

Browse all side effects of Flonase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gangrene:

Gangrene (652 drugs)

Browse all the conditions that are associated with Gangrene:

Gangrene (721 conditions)

Related publications that referenced our studies

Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .
Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone propionate (the active ingredients of Flonase) and Flonase (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.